SynthesisFrontiers in immunology2022

Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.

Stefanie Steiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.